Krystal Biotech gains UK approval for VYJUVEK gene therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. ACN
6. NVDA
7. IBM
8. SPY
9. PFE
10. TSLA

Go back to Krystal Biotech gains UK approval for VYJUVEK gene therapy
(NASDAQ: KRYS) Delayed: 343.09 -0.34 (0.1%)
Previous Close $343.43    52 Week High $ 
Open $339.21    52 Week Low $ 
Day High $346.82    P/E N/A 
Day Low $337.60    EPS $ 
Volume 114,143